Table 1 Baseline clinical and demographic data
all patients | Symptomatic | Asymptomatic | |
|---|---|---|---|
No. of patients | 96 | 48 | 48 |
Sex (M:F) | 56:40 | 25:23 | 31:17 |
Age (year) | 61.1 ± 9.0 | 61.2 ± 9.8 | 61.0 ± 8.2 |
Duration of dialysis (months) | 17.4 ± 23.4 | 19.1 ± 24.7 | 15.6 ± 22.2 |
Body height (cm) | 162.1 ± 6.6 | 162.3 ± 6.3 | 161.9 ± 7.0 |
Body weight (kg) | 65.5 ± 10.8 | 69.2 ± 9.9 | 61.8 ± 10.5 |
Body mass index (kg/m2) | 24.9 ± 3.8 | 26.3 ± 3.6 | 23.6 ± 3.6 |
Blood pressure (mmHg) | |||
Systolic | 146 ± 21 | 146 ± 22 | 146 ± 20 |
Diastolic | 75 ± 12 | 74 ± 12 | 76 ± 13 |
Causes of renal failure, no. of cases (%) | |||
Diabetic nephropathy | 54 (56.3%) | 31 (64.6%) | 23 (47.9%) |
Glomerulonephritis | 15 (15.6%) | 5 (10.4%) | 10 (20.8%) |
Hypertensive nephrosclerosis | 7 (7.3%) | 3 (6.3%) | 4 (8.3%) |
Polycystic kidney | 5 (5.2%) | 4 (8.3%) | 1 (2.1%) |
Obstructive uropathy | 0 | 0 | 0 |
Others / unknown | 15 (15.6%) | 5 (10.4%) | 10 (20.8%) |
Comorbidities, no. of cases (%) | |||
Diabetes | 67 (69.8%) | 34 (70.8%) | 33 (68.8%) |
Ischemic heart disease | 20 (20.8%) | 9 (18.8%) | 11 (22.9%) |
Cerebrovascular disease | 13 (13.5%) | 10 (20.8%) | 3 (6.3%) |
Charlson’s Comorbidity Index | 6.1 ± 2.2 | 6.4 ± 2.2 | 6.0 ± 2.1 |